JOLIMARK Reports Narrower Interim Loss for Six-Month Period

Stock News
Aug 29

JOLIMARK (02028) has released its interim results for the six months ended June 30, 2026, showing a reduction in its attributable loss.

The company recorded revenue of RMB 62.007 million, marking a year-on-year decline of 11.66%. Meanwhile, the loss attributable to shareholders narrowed to RMB 24.359 million, representing a decrease of 21.26% compared to the prior corresponding period. Basic loss per share stood at RMB 0.039.

According to the company's announcement, the primary factors driving the attributable loss in the first half of 2026 include weak demand for printers stemming from the comprehensive rollout of digital electronic invoicing across mainland China. Additionally, the medical products segment has yet to achieve meaningful scale, and the company recognized asset impairments during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10